— Know what they know.
Not Investment Advice

228760.KS KSC

Genomictree Inc
1W: +1.9% 1M: -22.0% 3M: +51.1% 1Y: +27.4% 3Y: -7.3% 5Y: -24.6%
₩21,100.00
Last traded 2024-08-14 — delisted
KSC · Healthcare · Biotechnology · ₩517.5B mcap · 20M float · 2.13% daily turnover

📊 Key Metrics

TTM
₩2B
Revenue
+8.7% YoY
₩-9,640M
Net Income
-0.8% YoY
₩-13,148M
Free Cash Flow
+16.9% YoY
-103.4%
Gross Margin
-793.9%
Op. Margin
-510.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-7.7%
ROA-7.3%
ROIC-23.6%

Valuation

P/E-32.6
P/B2.4
EV/EBITDA-49.9

Leverage

Debt/Equity0.00
Current Ratio56.88
Interest Cov.-26.4x

Quality Scores

Piotroski F3/9
Altman Z100.98
Beneish M1.08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms